Clari Vest Asset Management LLC Spectrum Pharmaceuticals Inc Transaction History

Clari Vest Asset Management LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 12, 2020	SELL	$3.5 - $10.35 $515,487 - $1.52 Million	-147,282 Closed	0 $0
Q3 2019 Nov 12, 2019	SELL	$7.03 - $9.7 $14,060 - $19,400	-2,000 Reduced 1.34%	147,282 $1.22 Million
Q2 2019 Aug 16, 2019	BUY	$7.36 - $11.26 $355,223 - $543,452	48,264 Added 47.78%	149,282 $1.29 Million
Q1 2019 May 13, 2019	SELL	$9.08 - $11.84 $148,094 - $193,110	-16,310 Reduced 13.9%	101,018 $1.08 Million
Q4 2018 Feb 05, 2019	BUY	$6.39 - $16.99 $256,021 - $680,721	40,066 Added 51.86%	117,328 $1.03 Million
Q3 2018 Nov 07, 2018	SELL	$16.52 - $24.82 $1.18 Million - $1.78 Million	-71,635 Reduced 48.11%	77,262 $1.3 Million
Q2 2018 Aug 10, 2018	SELL	$14.31 - $21.75 $1.02 Million - $1.54 Million	-71,021 Reduced 32.29%	148,897 $3.12 Million
Q1 2018 May 08, 2018	SELL	$16.09 - $23.07 $396,312 - $568,237	-24,631 Reduced 10.07%	219,918 $3.54 Million
Q4 2017 Feb 13, 2018	SELL	$13.36 - $20.73 $500,666 - $776,856	-37,475 Reduced 13.29%	244,549 $4.64 Million
Q3 2017 Nov 07, 2017	BUY	$8.75 - $14.07 $351,006 - $564,418	40,115 Added 16.58%	282,024 $3.97 Million
Q2 2017 Nov 20, 2017	BUY	N/A	241,909	241,909 $1.8 Million

115K

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

Get notified when there are updates to the investment portfolio of Clari Vest Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Clari Vest Asset Management LLC with notifications on news.